scholarly journals The Effect of Pyridoxine Hydrochloride Supplementation on Leptin, Adiponectin, Glycemic Indices, and Anthropometric Indices in Obese and Overweight Women

2021 ◽  
Vol 10 (3) ◽  
pp. 230
Author(s):  
Fatemeh Haidari ◽  
Majid Mohammadshahi ◽  
Mehdi Zarei ◽  
Mohammad Hosein Haghighizadeh ◽  
Fatemeh Mirzaee
2020 ◽  
Author(s):  
Fatemeh Haidari ◽  
Majid Mohammadshahi ◽  
Mehdi Zarei ◽  
Mohammad Hosein Haghighizadeh ◽  
Fatemeh Mirzaee

Abstract Background and Objectives: Obesity has reached epidemic proportions globally. Among several methods for treating obesity, the use of dietary supplements is common recently. One supplement that can help in this regard might be vitamin B6 in high doses.The objective of this study was to evaluate the efficacy of pyridoxine hydrochloride supplementation on anthropometric measurements, body composition, visceral adiposity index and metabolic status in obese and overweight women.Methods and Study Design: In this randomized controlled clinical trial, 44 obese and overweight women aged 18–50 years were selected and divided randomly into two groups: an intervention group (receiving 80 mg pyridoxine hydrochloride supplement for 8 weeks) and control group (receiving placebo for 8 weeks). Results: In the pyridoxine hydrochloride group, weight(p=0.01), body mass index(p=0.009), fat mass(p=0.003), waist circumference(p=0.005), visceral adiposity index(p=0.001), fasting insulin, Insulin Resistance(HOMA-IR), Total cholesterol, low density lipoprotein(LDL), Triglycerides (TG) and leptin(p<0.001) decreased whereas adiponectin(p<0.001) increased in comparison to the baseline values. There was a significant difference in fat mass, visceral adiposity index, fasting insulin, HOMA-IR and TG between pyridoxine hydrochloride and control groups following intervention in adjusted models(p<0.05).Conclusions: The findings suggest that vitamin B6 supplementation may be effective in reducing BMI and improving body composition and biochemical factors associated with obesity.Trial registration: The trial was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (reference number: ir.ajums.rec.1394.254) and was registered at Iranian Registry of Clinical Trials (code: IRCT20181002041206N1).


2018 ◽  
Vol 9 (1) ◽  
pp. 63 ◽  
Author(s):  
MohammadHassan Entezari ◽  
ZahraSadat Khosravi ◽  
Marzieh Kafeshani ◽  
Parastoo Tavasoli ◽  
AkbarHassan Zadeh

2021 ◽  
Author(s):  
Fatemeh Haidari ◽  
Majid Mohammadshahi ◽  
Mehdi Zarei ◽  
Mohammad Hosein Haghighizadeh ◽  
Fatemeh Mirzaee

Abstract Background and Objectives: Obesity has reached epidemic proportions globally. Among several methods for treating obesity, the use of dietary supplements is common recently. One supplement that can help in this regard might be vitamin B6 in high doses.The objective of this study was to evaluate the efficacy of pyridoxine hydrochloride supplementation on anthropometric measurements, body composition, visceral adiposity index and metabolic status in obese and overweight women.Methods and Study Design: In this randomized controlled clinical trial, 44 obese and overweight women aged 18–50 years were selected and divided randomly into two groups: an intervention group (receiving 80 mg pyridoxine hydrochloride supplement for 8 weeks) and control group (receiving placebo for 8 weeks). Results: In the pyridoxine hydrochloride group, weight(p=0.01), body mass index(p=0.009), fat mass(p=0.003), waist circumference(p=0.005), visceral adiposity index(p=0.001), fasting insulin, Insulin Resistance(HOMA-IR), Total cholesterol, low density lipoprotein(LDL), Triglycerides (TG) and leptin(p<0.001) decreased whereas adiponectin(p<0.001) increased in comparison to the baseline values. There was a significant difference in fat mass, visceral adiposity index, fasting insulin, HOMA-IR and TG between pyridoxine hydrochloride and control groups following intervention in adjusted models(p<0.05).Conclusions: The findings suggest that vitamin B6 supplementation may be effective in reducing BMI and improving body composition and biochemical factors associated with obesity.Trial registration: Iran Clinical Trials Registry: IRCT20181002041206N1. Registered on 31 October 2018, https://en.irct.ir/trial/34220.


2015 ◽  
Vol 21 ◽  
pp. 115-116
Author(s):  
Fakhraddeen Muhammad ◽  
Andrew Uloko ◽  
Ibrahim Gezawa ◽  
Mansur Ramalan ◽  
abdulrazaq habib

2004 ◽  
Vol 10 ◽  
pp. 41-42
Author(s):  
Sachin K. Jain ◽  
Ritesh Panwar ◽  
Siddharth Mukerjee

2014 ◽  
Vol 84 (1-2) ◽  
pp. 5-11 ◽  
Author(s):  
Eun Y. Jung ◽  
Sung C. Jun ◽  
Un J. Chang ◽  
Hyung J. Suh

Previously, we have found that the addition of L-ascorbic acid to chitosan enhanced the reduction in body weight gain in guinea pigs fed a high-fat diet. We hypothesized that the addition of L-ascorbic acid to chitosan would accelerate the reduction of body weight in humans, similar to the animal model. Overweight subjects administered chitosan with or without L-ascorbic acid for 8 weeks, were assigned to three groups: Control group (N = 26, placebo, vehicle only), Chito group (N = 27, 3 g/day chitosan), and Chito-vita group (N = 27, 3 g/day chitosan plus 2 g/day L-ascorbic acid). The body weights and body mass index (BMI) of the Chito and Chito-vita groups decreased significantly (p < 0.05) compared to the Control group. The BMI of the Chito-vita group decreased significantly compared to the Chito group (Chito: -1.0 kg/m2 vs. Chito-vita: -1.6 kg/m2, p < 0.05). The results showed that the chitosan enhanced reduction of body weight and BMI was accentuated by the addition of L-ascorbic acid. The fat mass, percentage body fat, body circumference, and skinfold thickness in the Chito and Chito-vita groups decreased more than the Control group; however, these parameters were not significantly different between the three groups. Chitosan combined with L-ascorbic acid may be useful for controlling body weight.


2020 ◽  
Author(s):  
Yeter Kitiş ◽  
Filiz Hisar ◽  
Kemal Macit Hisar

Sign in / Sign up

Export Citation Format

Share Document